Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTY
2701
Getty Realty Corp
GTY
$2.1B
| $2.48M | ﹤0.01% |
92,394
-23,902
| -21% | -$666K |
|
2702
CALL
VanEck Junior Gold Miners ETF
GDXJ
$7.01B
| $2.48M | ﹤0.01% |
+25,000
| New | +$1.92M |
|
|
2703
PUT
VanEck Junior Gold Miners ETF
GDXJ
$7.01B
| $2.48M | ﹤0.01% |
+25,000
| New | +$1.92M |
|
2704
NCR Voyix
VYX
$1.17B
| $2.47M | ﹤0.01% |
196,461
-82,150
| -29% | -$1.08M |
|
2705
Fortuna Silver Mines
FSM
$2.62B
| $2.46M | ﹤0.01% |
274,860
-51,724
| -16% | -$378K |
|
2706
Algonquin Power & Utilities
AQN
$4.46B
| $2.46M | ﹤0.01% |
458,482
-171,475
| -27% | -$986K |
|
2707
PUT
JetBlue
JBLU
$2.37B
| $2.46M | ﹤0.01% |
500,000
| – | – |
|
|
UXIN
2708
Uxin Ltd
UXIN
$308M
| $2.45M | ﹤0.01% |
709,256
+460,995
| +186% | +$1.76M |
|
2709
Liquidia Corp
LQDA
$7.42B
| $2.45M | ﹤0.01% |
107,866
-48,494
| -31% | -$1.05M |
|
|
LIF
2710
Life360
LIF
$4.54B
| $2.45M | ﹤0.01% |
23,063
-40,658
| -64% | -$3.42M |
|
2711
Skyward Specialty Insurance
SKWD
$2.46B
| $2.45M | ﹤0.01% |
51,504
-19,906
| -28% | -$996K |
|
2712
PUT
DexCom
DXCM
$32.6B
| $2.45M | ﹤0.01% |
36,400
-27,400
| -43% | -$2.17M |
|
2713
CALL
Blackrock
BLK
$172B
| $2.45M | ﹤0.01% |
2,100
+900
| +75% | +$1.01M |
|
|
2714
PUT
Blackrock
BLK
$172B
| $2.45M | ﹤0.01% |
+2,100
| New | +$2.35M |
|
|
DAWN
2715
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.45M | ﹤0.01% |
347,185
-924
| -0.3% | -$6.36K |
|
2716
PureCycle Technologies
PCT
$1.38B
| $2.45M | ﹤0.01% |
185,945
-68,736
| -27% | -$955K |
|
2717
Immunome
IMNM
$2.59B
| $2.44M | ﹤0.01% |
208,513
-21,360
| -9% | -$212K |
|
2718
Crescent Energy
CRGY
$3.76B
| $2.44M | ﹤0.01% |
273,656
-74,786
| -21% | -$679K |
|
2719
MiMedx Group
MDXG
$643M
| $2.44M | ﹤0.01% |
349,058
-58,663
| -14% | -$408K |
|
|
LTC
2720
LTC Properties
LTC
$2.02B
| $2.44M | ﹤0.01% |
66,099
-20,818
| -24% | -$743K |
|
2721
Harmonic Inc
HLIT
$1.26B
| $2.43M | ﹤0.01% |
239,009
+25,206
| +12% | +$238K |
|
2722
Sphere Entertainment
SPHR
$5.36B
| $2.43M | ﹤0.01% |
39,164
-730,301
| -95% | -$34.5M |
|
2723
Stepan Co
SCL
$1.42B
| $2.43M | ﹤0.01% |
50,936
-3,411
| -6% | -$177K |
|
2724
Energizer
ENR
$1.48B
| $2.43M | ﹤0.01% |
97,506
-49,846
| -34% | -$1.3M |
|
2725
ACV Auctions
ACVA
$1.39B
| $2.43M | ﹤0.01% |
244,885
-82,064
| -25% | -$1.05M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.